Annual Total Liabilities
$1.66 M
-$1.42 M-46.18%
December 31, 2023
Summary
- As of February 8, 2025, FRTX annual total liabilities is $1.66 million, with the most recent change of -$1.42 million (-46.18%) on December 31, 2023.
- During the last 3 years, FRTX annual total liabilities has fallen by -$4.84 million (-74.52%).
- FRTX annual total liabilities is now -92.07% below its all-time high of $20.89 million, reached on December 1, 2003.
Performance
FRTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.66 M
-$452.00 K-21.44%
December 31, 2023
Summary
- As of February 8, 2025, FRTX quarterly total liabilities is $1.66 million, with the most recent change of -$452.00 thousand (-21.44%) on December 31, 2023.
- Over the past year, FRTX quarterly total liabilities has dropped by -$452.00 thousand (-21.44%).
- FRTX quarterly total liabilities is now -92.41% below its all-time high of $21.83 million, reached on June 1, 2003.
Performance
FRTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
FRTX Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -46.2% | -21.4% |
3 y3 years | -74.5% | -21.4% |
5 y5 years | -53.8% | -21.4% |
FRTX Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -65.6% | at low | -65.6% | at low |
5 y | 5-year | -84.3% | at low | -84.3% | at low |
alltime | all time | -92.1% | +38.0% | -92.4% | +42.9% |
Fresh Tracks Therapeutics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $1.66 M(-46.2%) | $1.66 M(-21.4%) |
Sep 2023 | - | $2.11 M(+13.9%) |
Jun 2023 | - | $1.85 M(-11.9%) |
Mar 2023 | - | $2.10 M(-31.7%) |
Dec 2022 | $3.08 M(-36.0%) | $3.08 M(-4.6%) |
Sep 2022 | - | $3.22 M(+12.3%) |
Jun 2022 | - | $2.87 M(-39.5%) |
Mar 2022 | - | $4.74 M(-1.4%) |
Dec 2021 | $4.81 M(-26.0%) | - |
Dec 2021 | - | $4.81 M(+14.0%) |
Sep 2021 | - | $4.22 M(-37.2%) |
Jun 2021 | - | $6.72 M(-30.8%) |
Mar 2021 | - | $9.71 M(+49.4%) |
Dec 2020 | $6.50 M(-38.5%) | $6.50 M(-15.5%) |
Sep 2020 | - | $7.69 M(+2.3%) |
Jun 2020 | - | $7.52 M(+5.3%) |
Mar 2020 | - | $7.14 M(-32.4%) |
Dec 2019 | $10.57 M(+195.2%) | $10.57 M(-19.6%) |
Sep 2019 | - | $13.14 M(+1034.1%) |
Jun 2019 | - | $1.16 M(-54.0%) |
Mar 2019 | - | $2.52 M(-29.6%) |
Dec 2018 | $3.58 M(-78.8%) | $3.58 M(+1.4%) |
Sep 2018 | - | $3.53 M(+11.0%) |
Jun 2018 | - | $3.18 M(+0.8%) |
Mar 2018 | - | $3.16 M(-81.3%) |
Dec 2017 | $16.92 M(+136.8%) | $16.92 M(+42.4%) |
Sep 2017 | - | $11.88 M(+8.2%) |
Jun 2017 | - | $10.98 M(+24.0%) |
Mar 2017 | - | $8.86 M(+23.9%) |
Dec 2016 | $7.14 M(+58.0%) | $7.14 M(+80.2%) |
Sep 2016 | - | $3.96 M(+16.5%) |
Jun 2016 | - | $3.40 M(-11.7%) |
Mar 2016 | - | $3.85 M(-14.8%) |
Dec 2015 | $4.52 M(-25.4%) | $4.52 M(-24.2%) |
Sep 2015 | - | $5.97 M(+15.6%) |
Jun 2015 | - | $5.16 M(+6.1%) |
Mar 2015 | - | $4.87 M(-19.7%) |
Dec 2014 | $6.06 M(+22.6%) | $6.06 M(+7.9%) |
Sep 2014 | - | $5.61 M(+15.2%) |
Jun 2014 | - | $4.87 M(+7.9%) |
Mar 2014 | - | $4.52 M(-8.6%) |
Dec 2013 | $4.94 M(-33.6%) | $4.94 M(-25.1%) |
Sep 2013 | - | $6.60 M(-12.5%) |
Jun 2013 | - | $7.54 M(+10.2%) |
Mar 2013 | - | $6.84 M(-7.9%) |
Dec 2012 | $7.44 M(-11.7%) | $7.44 M(+1.4%) |
Sep 2012 | - | $7.33 M(+6.5%) |
Jun 2012 | - | $6.88 M(-24.8%) |
Mar 2012 | - | $9.16 M(+8.7%) |
Dec 2011 | $8.43 M(-1.4%) | $8.43 M(+12.0%) |
Sep 2011 | - | $7.52 M(-3.2%) |
Jun 2011 | - | $7.77 M(+2.3%) |
Mar 2011 | - | $7.59 M(-11.2%) |
Dec 2010 | $8.54 M(-31.0%) | $8.54 M(-6.7%) |
Sep 2010 | - | $9.15 M(-0.7%) |
Jun 2010 | - | $9.22 M(-9.7%) |
Mar 2010 | - | $10.20 M(-17.7%) |
Dec 2009 | $12.39 M(+18.6%) | $12.39 M(+4.2%) |
Sep 2009 | - | $11.89 M(+4.7%) |
Jun 2009 | - | $11.36 M(+9.6%) |
Mar 2009 | - | $10.37 M(-0.7%) |
Dec 2008 | $10.44 M | $10.44 M(+4.4%) |
Sep 2008 | - | $10.00 M(-0.6%) |
Jun 2008 | - | $10.07 M(+18.7%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2008 | - | $8.48 M(-20.5%) |
Dec 2007 | $10.67 M(-4.1%) | $10.67 M(+26.8%) |
Sep 2007 | - | $8.42 M(+2.2%) |
Jun 2007 | - | $8.23 M(-13.6%) |
Mar 2007 | - | $9.53 M(-14.3%) |
Dec 2006 | $11.13 M(-21.8%) | $11.13 M(+7.7%) |
Sep 2006 | - | $10.33 M(-1.5%) |
Jun 2006 | - | $10.49 M(-14.4%) |
Mar 2006 | - | $12.26 M(-13.8%) |
Dec 2005 | $14.22 M(-22.3%) | $14.22 M(-5.6%) |
Sep 2005 | - | $15.07 M(-8.5%) |
Jun 2005 | - | $16.47 M(+3.6%) |
Mar 2005 | - | $15.90 M(-13.2%) |
Dec 2004 | $18.32 M(-12.3%) | $18.32 M(+7.5%) |
Sep 2004 | - | $17.04 M(-13.1%) |
Jun 2004 | - | $19.62 M(-9.7%) |
Mar 2004 | - | $21.73 M(+4.1%) |
Dec 2003 | $20.89 M(+38.1%) | $20.89 M(-1.4%) |
Sep 2003 | - | $21.19 M(-2.9%) |
Jun 2003 | - | $21.83 M(+52.1%) |
Mar 2003 | - | $14.35 M(-5.1%) |
Dec 2002 | $15.12 M(+22.6%) | $15.12 M(+15.2%) |
Sep 2002 | - | $13.13 M(+8.2%) |
Jun 2002 | - | $12.14 M(+11.7%) |
Mar 2002 | - | $10.87 M(-11.9%) |
Dec 2001 | $12.34 M(+1.9%) | $12.34 M(-7.9%) |
Sep 2001 | - | $13.39 M(+6.4%) |
Jun 2001 | - | $12.58 M(+1.7%) |
Mar 2001 | - | $12.37 M(+2.2%) |
Dec 2000 | $12.11 M(+89.2%) | $12.11 M(+13.3%) |
Sep 2000 | - | $10.69 M(-8.9%) |
Jun 2000 | - | $11.74 M(+9.1%) |
Mar 2000 | - | $10.76 M(+68.1%) |
Dec 1999 | $6.40 M(+60.0%) | $6.40 M(+28.0%) |
Sep 1999 | - | $5.00 M(+8.7%) |
Jun 1999 | - | $4.60 M(+4.5%) |
Mar 1999 | - | $4.40 M(+10.0%) |
Dec 1998 | $4.00 M(+14.3%) | $4.00 M(+8.1%) |
Sep 1998 | - | $3.70 M(-2.6%) |
Jun 1998 | - | $3.80 M(+15.2%) |
Mar 1998 | - | $3.30 M(-5.7%) |
Dec 1997 | $3.50 M(-12.5%) | $3.50 M(+12.9%) |
Sep 1997 | - | $3.10 M(-6.1%) |
Jun 1997 | - | $3.30 M(-5.7%) |
Mar 1997 | - | $3.50 M(-12.5%) |
Dec 1996 | $4.00 M(+122.2%) | $4.00 M(+2.6%) |
Sep 1996 | - | $3.90 M(+50.0%) |
Jun 1996 | - | $2.60 M(+62.5%) |
Mar 1996 | - | $1.60 M(-11.1%) |
Dec 1995 | $1.80 M(-25.0%) | $1.80 M(-5.3%) |
Sep 1995 | - | $1.90 M(+26.7%) |
Jun 1995 | - | $1.50 M(-16.7%) |
Mar 1995 | - | $1.80 M(-25.0%) |
Dec 1994 | $2.40 M(-11.1%) | $2.40 M(+4.3%) |
Sep 1994 | - | $2.30 M(0.0%) |
Jun 1994 | - | $2.30 M(+15.0%) |
Mar 1994 | - | $2.00 M(-25.9%) |
Dec 1993 | $2.70 M(-20.6%) | $2.70 M(+8.0%) |
Sep 1993 | - | $2.50 M(-16.7%) |
Jun 1993 | - | $3.00 M(+87.5%) |
Mar 1993 | - | $1.60 M(-52.9%) |
Dec 1992 | $3.40 M(+112.5%) | $3.40 M(+112.5%) |
Dec 1991 | $1.60 M(+33.3%) | $1.60 M(+33.3%) |
Dec 1990 | $1.20 M | $1.20 M |
FAQ
- What is Fresh Tracks Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics annual total liabilities year-on-year change?
- What is Fresh Tracks Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics quarterly total liabilities year-on-year change?
What is Fresh Tracks Therapeutics annual total liabilities?
The current annual total liabilities of FRTX is $1.66 M
What is the all time high annual total liabilities for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual total liabilities is $20.89 M
What is Fresh Tracks Therapeutics annual total liabilities year-on-year change?
Over the past year, FRTX annual total liabilities has changed by -$1.42 M (-46.18%)
What is Fresh Tracks Therapeutics quarterly total liabilities?
The current quarterly total liabilities of FRTX is $1.66 M
What is the all time high quarterly total liabilities for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly total liabilities is $21.83 M
What is Fresh Tracks Therapeutics quarterly total liabilities year-on-year change?
Over the past year, FRTX quarterly total liabilities has changed by -$452.00 K (-21.44%)